[en] OBJECTIVES: The aims of this study were to assess the survival rate at one year of patients receiving long-term oxygen therapy (LTOT) as prescribed by the National Institute for Health and Disability Insurance's imposed criteria based on international recommendations, to search for short-term predictive factors for mortality and to measure the impact of LTOT on the frequency of hospitalization due to COPD exacerbations. METHODS: We conducted a retrospective analysis of 416 patients suffering from chronic respiratory insufficiency and started on long-term oxygen therapy between 2012 and 2014. The survival curves were estimated by the Kaplan-Meier method. Cox regression models were used to estimate the impact of the variables on survival. The evolution of patients hospitalized for COPD exacerbation was analysed by the McNemar test. RESULTS: The average age of our cohort was 70+/-10 years. It included 57% women and 78% patients with COPD. The one-year survival rate (n=416) under LTOT was 75%. Identified predictive mortality factors were coronary insufficiency [HR (95% CI): 1.8 (1.2-2.8); P=0.0083], reduction of the left ventricular ejection fraction [HR (95% CI): 2.5 (1.3-4.9); P=0.0080], the presence of osteoporosis [HR (95% CI): 1.7 (1.0-2.9); P=0.040]. There was a 28% reduction in the frequency of hospitalization for exacerbations of COPD during the year after starting LTOT. CONCLUSIONS: Mortality at one year with LTOT was about 25%. Factors predictive of mortality at one year included coronary insufficiency, reduction of the left ventricular ejection fraction and osteoporosis. LTOT seems to reduce hospitalizations due to exacerbations of COPD.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
VAN CAUWENBERGE, Hélène ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de pneumologie - allergologie
Heffner, J.E., The story of oxygen. Respir Care, 58, 2013, 1.
Nocturnal Oxygen Therapy trial Group, Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. Ann Intern Med 93 (1980), 931–938.
Medical Research Council Working Party, Report of long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1 (1981), 681–685.
Global Initiative for Chronic Obstructive Lung Disease (GOLD), Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2017 report. Accessible sur; https://goldcopd.org.
MC Donald, F., Whyte, K., Jenkins, S., et al. Clinical practice guideline on adult domiciliary oxygen therapy executive summary from the Thoracic Society of Australia and New Zealand. Respirology 21 (2016), 76–78.
LOTT, A randomized trial of long-term oxygen for COPD with moderate desaturation. N Engl J Med 375 (2016), 1617–1627.
Lima, D., Coleta, K., Tanni, S., et al. Potentially modifiable predictors of mortality in patients treated with long-term oxygen therapy. Respir Med 105 (2011), 470–476.
Turner, A.M., Tamasi, L., Schleich, F., et al. Clinically relevant subgroups in COPD and asthma. Eur Repir Rev 24 (2015), 283–298.
Mathers, C., Loncar, D., Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med, 3, 2006, e442.
Couillard, A., Les facteurs pronostiques dans la BPCO: la tête, les jambes et le souffle. Rev Mal Respir 28 (2011), 174–186.
Ringbaek, T.J., Lange, P., Trends in long-term oxygen therapy for COPD in Denmark from 2011 to 2010. Respir Med 108 (2014), 511–516.
Cranston, J.M., Nguyen, A.M., Crockett, A.J., The relative survival of COPD patients on long-term oxygen therapy in Australia: a comparative study. Respirology 9 (2004), 237–242.
Foucher, P., Baudouin, N., Merati, M., et al. Relative survival analysis of 252 patients with COPD receiving long-term oxygen therapy. Chest 113 (1998), 1580–1587.
Dela Coleta, K., Silveira, L., Lima, D., et al. Predictors of first-year survival in patients with advanced COPD treated using long-term oxygen therapy. Respir Med 102 (2008), 512–518.
Ringbaek, T.J., Lange, P., The impact of the Danish oxygen register on adherence to guidelines for long-term oxygen therapy in COPD patients. Repir Med 100 (2006), 218–225.
Fuhrman, C., Boussac-Zarebska, M., Roche, N., et al. Oxygénothérapie de longue durée en France, 2006–2011. Rev Mal Respir 31 (2014), 421–429.
Ekström, M.P., Jogréus, C., Ström, K.E., Comorbidity and sex-related differences in mortality in oxygen-dependent chronic obstructive pulmonary disease. PLoS One, 7, 2012, 4e35806.
Inoue, D., Watanabe, R., Okazaki, R., COPD and osteoporosis: links, risks, and treatment challenges. Int J COPD 11 (2016), 637–648.
Murphy, P., Rehal, S., Arbane, G., et al. Effect of home noninvasive ventilation with oxygen therapy vs. oxygen therapy alone on hospital readmission or death after an acute COPD exacerbation. JAMA 317 (2017), 2177–2186.
Köhnlein, T., Windisch, W., Köhler, D., et al. Noninvasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. Lancet Respir Med 2 (2014), 698–705.
Pirotte, M., Guiot, J., Beguin, Y., et al. L'anémie dans la bronchopneumopathie chronique obstructive sévère. Rev Med Liege 71 (2016), 488–494.
Chambellan, A., Chailleux, E., Similowski, T., Pronostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest 128 (2005), 1201–1208.
Corhay, J.L., Vincken, W., Schlesser, M., et al. Chronic bronchitis in COPD patients is associated with increased risk of exacerbations: a cross-sectional multicentre study. Int J Clin Pract 67 (2013), 1294–1301.
Wedzicha, J., Brill, S., Allison, J., et al. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease. BMC Med, 11, 2013, 181.
Lindberg, A., Sawalha, S., Hedman, L., et al. Subjects with COPD and productive cough have an increased risk for exacerbations and death. Repir Med 109 (2015), 88–95.
Hurst, J., Vestbo, J., Anzueto, A., et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 363 (2010), 1128–1138.
Cho, K.H., Kim, Y.S., Nam, C.M., et al. Home oxygen therapy reduces risk of hospitalisation in patients with chronic obstructive pulmonary disease: a population-based retrospective cohort study, 2005–2012. BMJ Open, 5, 2015, e009065.
